Who's in the business of saving lives?

Journal of Medicine and Philosophy

Volumn 31, Issue 5, 2006, Pages 465-482

  Chang, Pepe Lee ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Drugs; Impoverished; Obligation; Pharmaceutical; Responsibility

Indexed keywords

BIOETHICS; BIOMEDICINE; DEVELOPING COUNTRY; DRUG INDUSTRY; LIFE EXPECTANCY; POVERTY; RESPONSIBILITY; REVIEW; SOCIOLOGY;

DEVELOPING COUNTRIES; DRUG INDUSTRY; ETHICAL THEORY; ETHICS, BUSINESS; HUMANS; MORAL OBLIGATIONS; MORTALITY; POVERTY; SOCIAL RESPONSIBILITY;

EID: 33750560015     PISSN: 03605310     EISSN: 17445019     Source Type: Journal    
DOI: 10.1080/03605310600912667     Document Type: Review

References (31)

1. Angell, M. (2004). The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York: Random House.
2. Brock, D.W. (2001). 'Some questions about the moral responsibilities of drug companies in developing countries,' Developing World Bioethics, 1, 33-37.
3. Carroll, A. B. (1979). 'A three-dimensional conceptual model for corporate social performance,' Academy of Management Review, 4, 497-505.
4. Carroll, A. B. (1997). 'Social responsibility (entry),' in E. R. Freeman and P. Werhane (Eds.), Encyclopedic Dictionary of Business Ethics (p. 594). Oxford: Blackwell Publishing.
5. Conway, G. (1999) GM foods can save lives-if we use them sensibly [On-line]. Available: http://www.biotech-info.net/saving_lives.html. Accessed February 6, 2006.
6. Dancy, J. (1993). Moral Reasons. Oxford: Blackwell Publishing.
7. Daniels, N. (2001). 'Social responsibility and global pharmaceutical companies,' Developing World Bioethics, 1, 38-41.
8. Davis, K., and Blomstrom, R. (1975). Business and Society: Environment and Responsibility. New York: McGraw-Hill.
9. De George, R. T. (2005). 'Intellectual property and pharmaceutical drugs: An ethical analysis,' Business Ethics Quarterly, 15, 549-575.
10. Elliot, L. A., and Schroth, R. J. (2002). How Companies Lie. New York: Crown Publishing.
11. Fortune Magazine. (2002). 2002 Fortune 500 [On-line]. Available: http://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321417/index. htm. Accessed February 6, 2006.
12. Frank, R. H. (2002). 'Can socially responsible firms survive in a competitive environment?,' in T. Donaldson, P. Werhane, & M. Cording (Eds.), Ethical Issues in Business: A Philosophical Approach (pp. 252-262). Upper Saddle River, NJ: Prentice Hall.
13. Freeman, R. E. (2002). 'Stakeholder theory of the modern corporation,' in T. Donaldson, P. Werhane, and M. Cording (Eds.), Ethical Issues in Business: A Philosophical Approach (pp. 38-48). Upper Saddle River, NJ: Prentice Hall.
14. Friedman, M. (2002). 'The social responsibility of business is to increase its profits,' in T. Donaldson, P. Werhane, and M. Cording (Eds.), Ethical Issues in Business: A Philosophical Approach (pp. 33-37). Upper Saddle River, NJ: Prentice Hall.
15. Hart, H. L. A. (1995/1958). 'Positivism and the separation of law and morals,' in J. Feinberg and H. Gross (Eds.), Philosophy of Law, 5th ed. (pp. 56-72). Belmont, CA: Wadsworth Publishing Company.
16. Kant, I. (1996/1797). The Metaphysics of Morals. Mary Gregor (Ed.) Cambridge: Cambridge University Press.
17. Leisinger, K. M. (2005). 'The corporate social responsibility of the pharmaceutical industry: Idealism without illusion and realism without resignation,' Business Ethics Quarterly, 15, 577-594.
18. McAlister, R. E. (2005). Energy-related inventions [On-line]. Available: http://www.lightparty.com/Energy/AmericanHydrogenAsso.html. Accessed February 6, 2006.
19. McGuire, J. W. (1963). Business and Society. New York: McGraw-Hill.
20. O'Neill, O. (1980). 'Kantian approached to some famine problems,' in T. Regan (Ed.), Matters of Life (pp. 285-294). New York: McGraw-Hill.
21. Progressive, The (2001) AIDS culprits-multinational drug companies overpricing in Africa [On-line]. Available: http://www.thirdworldtraveler.com/ Health/AIDS_Culprits.html. Accessed February 6, 2006.
22. Resnik, D. B. (2001). 'Developing drugs for the developing world: An economic, legal, moral, and political dilemma,' Developing World Bioethics, 1, 11-32.
23. Ross, W. D. (1930). The Right and the Good. Oxford: Oxford University Press.
24. Sen, A. (1993). 'Does business ethics make economic sense?,' Business Ethics Quarterly, 3, 45-54.
25. Singer, P. (1972). 'Famine, affluence, and morality,' Philosophy and Public Affairs, 1, 229-243.
26. Soule, E. (2002). 'Managerial moral strategies-in search of a few good principles,' Academy of Management Review, 27, 114-124.
27. Steidlmeier, P. (1997). 'Intellectual property (entry),' in E. R. Freeman and P. Werhane (Eds.), Encyclopedic Dictionary of Business Ethics (pp. 337-339). Oxford: Blackwell Publishing.
28. Trevino, L. K., and Nelson, K. A. (2004). Managing Business Ethics: Straight Talk About How to Do It Right. Hoboken: Wiley Publishing.
29. Van Gelder, A. (2005). NGOs on drugs [On-line]. Available: http://www.aegis.org/news/wsj/2005/WJ051001.html. Accessed February 6, 2006.
30. Versweyvel, L. (2003). Cedara and Alion join forces to develop life-saving technology for military medical emergencies. [On-line]. Available: http://www.hoise.com/vmw/04/articles/vmw/LV-VM-01-04-12.html. Accessed February 6, 2006.
31. Whitman, D. B. (2000) Genetically modified foods: Harmful or helpful? [On-line]. Available: http://www.csa.com/discoveryguides/gmfood/overview.php. Accessed February 6, 2006.